Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study for ivWatch® in Prevention of Extravasation of Vesicants in an Oncology Setting

NCT06758011 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT06758011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06758011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study for ivWatch® in Prevention of Extravasation of Vesicants in an Oncology Setting
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2023
Completion date
January 26, 2026
Enrollment
2,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extravasation, oncology